KalVista Pharmaceuticals (KALV) Asset Utilization Ratio (2015 - 2025)
KalVista Pharmaceuticals recorded quarterly Asset Utilization Ratio of 0.31 in Q3 2025, up 412.41% quarter-over-quarter from 0.06 in Q2 2025, and up 619.87% year-over-year from 0.04 in Q3 2024.
KalVista Pharmaceuticals' Asset Utilization Ratio history runs 8 years deep, the most recent figure standing at 0.31 for Q3 2025.
- In Q3 2025, Asset Utilization Ratio rose 619.87% year-over-year to 0.31; the TTM figure through Jul 2025 stood at 0.31 (up 619.87% YoY), while the FY2025 annual figure was 0.05, down 81.06% from the prior year.
- Asset Utilization Ratio came in at 0.31 for Q3 2025 at KalVista Pharmaceuticals, up from 0.06 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.31 in Q3 2025 to a low of 0.04 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.47 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 0.29 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.37 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.85 |
| 10 | KalVista Pharmaceuticals | 1.44 Bn | 1.25 Bn | 56.41 Mn | 0.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | 0.31 |
| Apr 30, 2025 | 0.06 |
| Jul 31, 2024 | 0.04 |
| Apr 30, 2020 | 0.13 |
| Jan 31, 2020 | 0.11 |
| Oct 31, 2019 | 0.12 |
| Jul 31, 2019 | 0.13 |
| Apr 30, 2019 | 0.13 |
| Jan 31, 2019 | 0.14 |
| Oct 31, 2018 | 0.17 |
| Jul 31, 2018 | 0.20 |
| Apr 30, 2018 | 0.13 |
| Jan 31, 2018 | 0.07 |
| Oct 31, 2017 | 0.05 |
| Jul 31, 2017 | 0.02 |
| Apr 30, 2017 | 0.04 |
| Mar 31, 2016 | 0.00 |
| Dec 31, 2015 | 0.00 |
| Sep 30, 2015 | 0.00 |
| Jun 30, 2015 | 0.00 |
| Mar 31, 2015 | 0.00 |